Test Code ACL Panel Anti-Cardiolipin Panel
Useful For
To aid in the diagnosis of thrombotic disorders related to primary & secondary anti-phospholipid syndrome (APS)
Patient Preparation
No special patient preparation required
Collection Method
Venous collection
Minimum Volume
2 mL
Container
Gold Top Serum Separator
Preferred Specimen
Serum
Acceptable Specimens
Serum:
- Gold Top SST
- Red Top
Plasma:
- Light Geen Top (lithium heparin)
Reference or Target Ranges
ACL IgA: |
<20 |
ACL IgG: |
<20 |
ACL IgM: |
<20 |
Reportable Units
RLU
Critical Value
Not defined for this assay
Reasons for Rejection
Hemolysis Threshold |
N/A |
Icterus Threshold |
N/A |
Lipemia Threshold |
N/A |
Other |
QNS, contaminated, improperly labeled, improper specimen type |
Specimen Stability
Ambient |
N/A |
Refrigerated (4°C to 8°C) |
48 Hours |
Frozen(-70°C to 0°C) |
Indefinitely |
Performance Information
Days and Time Performed |
Tuesday, Thursday, and Friday 7 AM – 4 PM |
Expected Turn Around Time |
Within 7 days of arrival in lab |
Stat Availability |
No |
Performing Bench |
ANA |
Methodology/Method Description |
Bioflash – Chemilluminescence |
Additional Information/Important Notes
Anticardiolipin antibodies (ACA) may be associated with thrombosis and pregnancy morbidity and loss and may be a serologic part of the antiphospholipid syndrome. ACA can transiently increase in infections. The diagnosis of antiphospholipid syndrome (APS) requires an appropriate clinical picture and the presence of persistently positive antiphospholipid antibodies (anticardiolipin, lupus anticoagulant, or anti-beta2 glycoprotein-I). ACA of medium or high titer consistently positive when checked 12 weeks apart meets one of the criteria for APL syndrome. The significance of isolated elevated ACA IgA is uncertain.
CPT Codes
86147 x3
Panel Components
- ACL IgA
- ACL IgG
- ACL IgM